Executive alleges sexual harassment, retaliation at pharma company Martin Shkreli built
All is not well at Turing Pharmaceuticals.
The company rose to notoriety last year when its famously defiant former chief executive, Martin Shkreli, defended inflating the price of a decades-old drug by more than 4,000 percent. Now, a Turing Pharmaceuticals executive has filed a federal complaint, saying she faced retaliation after she complained of sexual harassment.
Nancy Retzlaff, Turings chief commercial officer, has accused company co-founder and former interim CEO Edwin Urrutia of sexually assaulting her this past spring, according to a complaint filed Monday with the Equal Employment Opportunity Commission obtained by The Washington Post.
Though Urrutia resigned from Turing after an investigation, Retzlaff says that ensuing retaliation by others in the company cost her stock and the CEO position she had been promised.
Read more: https://www.washingtonpost.com/news/business/wp/2016/08/24/executive-alleges-sexual-harassment-retaliation-at-pharma-company-martin-shkreli-built/